Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2C | Q5R387 | 7/20 | 0.43 |
| ▸ | PLA2G10 | O15496 | 3/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | Q9HBH1 | 1/20 | 0.36 | |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GNPAT | O15228 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4205637 | 0.98 | PLA2G2C (0.44) | PLA2G2CPLA2G10GPR84ACE2PLA2G2A | |
| SCHEMBL5178306 | 0.98 | PLA2G2C (0.44) | PLA2G2CPLA2G10GPR84ACE2PLA2G2A | |
| Hydrochloric Acid SCHEMBL4199756 | 0.97 | PLA2G2C (0.43) | PLA2G2CPLA2G10GPR84ACE2PLA2G2A | |
| SCHEMBL4211648 | 0.89 | PLA2G10 (0.40) | PLA2G2CPLA2G10GPR84PLA2G2AALDH1A1 | |
| SCHEMBL6464991 | 0.83 | PLA2G2C (0.54) | PLA2G2CPLA2G10GPR84PLA2G2APDF | |
| SCHEMBL7944471 | 0.83 | PLA2G2C (0.54) | PLA2G2CPLA2G10GPR84PLA2G2APDF | |
| SCHEMBL14090829 | 0.83 | PLA2G2C (0.54) | PLA2G2CPLA2G10GPR84PLA2G2APDF | |
| SCHEMBL4192232 | 0.83 | CRAT (0.47) | PLA2G2C | |
| SCHEMBL4011955 | 0.82 | DPP7 (0.50) | PLA2G2CPLA2G10GPR84ACE2PDF | |
| SCHEMBL4007878 | 0.82 | DPP7 (0.50) | PLA2G2CPLA2G10GPR84ACE2PDF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247743-A1 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | PFIZER INC | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247743-A1 | PREPARATION OF BETA-AMINO ACIDS HAVING AFFINITY FOR THE ALPHA-2-DELTA PROTEIN | SCN2A, SCN1A, ORAI2 | PLA2G2C 1489/4885PLA2G10 3009/4885GPR84 2070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.